Haemonetics (HAE) Tops Q2 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $119.65 -0.12%
EPS Growth %: +1.6%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: +1.6%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.56, $0.02 better than the analyst estimate of $0.54. Revenue for the quarter came in at $242 million versus the consensus estimate of $233.45 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Oxford Square Capital Corp. (OXSQ) Misses Q3 EPS by 1c
- Qualcomm shares fall on Intel warning and legal concerns
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
